A RANDOMIZED TRIAL OF 2 MONTHS OF RIFAMPIN (RIF) AND PYRAZINAMIDE (PZA) VERSUS 12 MONTHS OF ISONIAZID (INH) FOR THE PREVENTION OF TUBERCULOSIS (TB) IN HIV–POSITIVE (+), PPD+ PATIENTS (ABSTRACT)

GORDIN, F., CHAISSON, R., & MATTS, J.. (1998). A RANDOMIZED TRIAL OF 2 MONTHS OF RIFAMPIN (RIF) AND PYRAZINAMIDE (PZA) VERSUS 12 MONTHS OF ISONIAZID (INH) FOR THE PREVENTION OF TUBERCULOSIS (TB) IN HIV–POSITIVE (+), PPD+ PATIENTS (ABSTRACT). CONFERENCE ON RETRO-VIRUSES AND, -(-), 0-0. SID. https://sid.ir/paper/536526/en

GORDIN F., CHAISSON R., MATTS J.. A RANDOMIZED TRIAL OF 2 MONTHS OF RIFAMPIN (RIF) AND PYRAZINAMIDE (PZA) VERSUS 12 MONTHS OF ISONIAZID (INH) FOR THE PREVENTION OF TUBERCULOSIS (TB) IN HIV–POSITIVE (+), PPD+ PATIENTS (ABSTRACT). CONFERENCE ON RETRO-VIRUSES AND[Internet]. 1998;-(-):0-0. Available from: https://sid.ir/paper/536526/en

F. GORDIN, R. CHAISSON, and J. MATTS, “A RANDOMIZED TRIAL OF 2 MONTHS OF RIFAMPIN (RIF) AND PYRAZINAMIDE (PZA) VERSUS 12 MONTHS OF ISONIAZID (INH) FOR THE PREVENTION OF TUBERCULOSIS (TB) IN HIV–POSITIVE (+), PPD+ PATIENTS (ABSTRACT),” CONFERENCE ON RETRO-VIRUSES AND, vol. -, no. -, pp. 0–0, 1998, [Online]. Available: https://sid.ir/paper/536526/en